{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:01:14Z","timestamp":1795104074426,"version":"4.10.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Posterior reversible encephalopathy syndrome (PRES) is usually a benign, yet underdiagnosed clinical condition associated with subacute to acute neurological manifestations primarily affecting white matter. PRES is reversible when recognized promptly and treated early by removal of the insulting factor; however, can lead to irreversible and life-threatening complications such as cerebral hemorrhage, cerebellar herniation, and refractory status epilepticus.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We utilized the National Inpatient Sample database provided by the Healthcare Cost and Utilization Project (HCUP-NIS) 2017 to investigate the demographic variables (age, sex, and race) for patients with PRES, concomitant comorbidities and conditions, inpatient complications, inpatient mortality, length of stay (LOS), and disposition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 635 admissions for patients aged 18\u2009years or older with PRES were identified. The mean age was 57.2\u2009\u00b1\u20090.6\u2009years old with most encounters for female patients (71.7%, <jats:italic>n<\/jats:italic>\u2009=\u2009455) and white as the most prevalent race. Half the patients in our study presented with seizures (50.1%, <jats:italic>n<\/jats:italic>\u2009=\u2009318), sixty-three patients (9.9%) presented with vision loss, and sixty-four patients (10.1%) had speech difficulty. In addition, 45.5% of patients had hypertensive crisis (<jats:italic>n<\/jats:italic>\u2009=\u2009289). 2.2% of hospitalizations had death as the outcome (<jats:italic>n<\/jats:italic>\u2009=\u200914). The mean LOS was 8.2 (\u00b10.3) days, and the mean total charges were $92,503 (\u00b1$5758). Inpatient mortality differed between males and females (1.7% vs. 2.4%) and by race (3.6% in black vs. 1.8% in white) but was ultimately determined to be not statistically significant. Most patients who present with vision disturbance have a high risk of intracranial hemorrhage. Furthermore, end-stage renal disease, atrial fibrillation, and malignancy seemed to be linked with a very high risk of mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PRES, formerly known as reversible posterior leukoencephalopathy, is a neurological disorder with variable presenting symptoms. Although it is generally a reversible condition, some patients suffer significant morbidity and even mortality. To the best of our knowledge, this is the largest retrospective cohort of PRES admissions that raises clinician awareness of clinical characteristics and outcomes of this syndrome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02143-6","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T10:03:37Z","timestamp":1615284217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical characteristics and outcomes of patients admitted to hospitals for posterior reversible encephalopathy syndrome: a retrospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Abbas","family":"Alshami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asseel","family":"Al-Bayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Douedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"issue":"4","key":"2143_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.14740\/wjon932w","volume":"6","author":"MA Hossain","year":"2015","unstructured":"Hossain MA, Jehangir W, Nai Q, et al. Posterior reversible encephalopathy syndrome in a bone marrow transplant patient: a complication of immunosuppressive drugs? World J Oncol. 2015;6(4):426\u20138. https:\/\/doi.org\/10.14740\/wjon932w.","journal-title":"World J Oncol"},{"issue":"3","key":"2143_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.7461\/jcen.2013.15.3.206","volume":"15","author":"SD Yoon","year":"2013","unstructured":"Yoon SD, Cho BM, Oh SM, Park SH, Jang IB, Lee JY. Clinical and radiological spectrum of posterior reversible encephalopathy syndrome. J Cerebrovasc Endovasc Neurosurg. 2013;15(3):206\u201313. https:\/\/doi.org\/10.7461\/jcen.2013.15.3.206.","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"issue":"3","key":"2143_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.33588\/rn.3803.2003342","volume":"38","author":"F L\u00f3pez-Garc\u00eda","year":"2004","unstructured":"L\u00f3pez-Garc\u00eda F, Amor\u00f3s-Mart\u00ednez F, Sempere AP. A reversible posterior leukoencephalopathy syndrome. Rev Neurol. 2004;38(3):261\u20136. https:\/\/doi.org\/10.33588\/rn.3803.2003342.","journal-title":"Rev Neurol"},{"issue":"2","key":"2143_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archneurol.2007.46","volume":"65","author":"VH Lee","year":"2008","unstructured":"Lee VH, Wijdicks EFM, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol. 2008;65(2):205\u201310. https:\/\/doi.org\/10.1001\/archneurol.2007.46.","journal-title":"Arch Neurol"},{"issue":"8","key":"2143_CR5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","volume":"264","author":"M Fischer","year":"2017","unstructured":"Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264(8):1608\u201316. https:\/\/doi.org\/10.1007\/s00415-016-8377-8.","journal-title":"J Neurol"},{"issue":"5","key":"2143_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4065\/mcp.2009.0590","volume":"85","author":"JE Fugate","year":"2010","unstructured":"Fugate JE, Claassen DO, Cloft HF, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85(5):427\u201332. https:\/\/doi.org\/10.4065\/mcp.2009.0590.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"2143_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ejpn.2014.04.014","volume":"18","author":"DM Cordelli","year":"2014","unstructured":"Cordelli DM, Masetti R, Ricci E, et al. Life-threatening complications of posterior reversible encephalopathy syndrome in children. Eur J Paediatr Neurol. 2014;18(5):632\u201340. https:\/\/doi.org\/10.1016\/j.ejpn.2014.04.014.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"2143_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/2193-1801-2-222","volume":"2","author":"Y Dong","year":"2013","unstructured":"Dong Y, Peng CY. Principled missing data methods for researchers. Springerplus. 2013;2(1):222. https:\/\/doi.org\/10.1186\/2193-1801-2-222.","journal-title":"Springerplus."},{"issue":"5","key":"2143_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.mehy.2014.02.022","volume":"82","author":"A Marra","year":"2014","unstructured":"Marra A, Vargas M, Striano P, Del Guercio L, Buonanno P, Servillo G. Posterior reversible encephalopathy syndrome: the endothelial hypotheses. Med Hypotheses. 2014;82(5):619\u201322. https:\/\/doi.org\/10.1016\/j.mehy.2014.02.022.","journal-title":"Med Hypotheses"},{"issue":"6","key":"2143_CR10","first-page":"1038","volume":"23","author":"DJ Covarrubias","year":"2002","unstructured":"Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol. 2002;23(6):1038\u201348.","journal-title":"Am J Neuroradiol"},{"issue":"7","key":"2143_CR11","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3174\/ajnr.A0549","volume":"28","author":"WS Bartynski","year":"2007","unstructured":"Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. Am J Neuroradiol. 2007;28(7):1320\u20137. https:\/\/doi.org\/10.3174\/ajnr.A0549.","journal-title":"Am J Neuroradiol"},{"issue":"6","key":"2143_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/hbm.20431","volume":"29","author":"VJ Schmithorst","year":"2008","unstructured":"Schmithorst VJ, Holland SK, Dardzinski BJ. Developmental differences in white matter architecture between boys and girls. Hum Brain Mapp. 2008;29(6):696\u2013710. https:\/\/doi.org\/10.1002\/hbm.20431.","journal-title":"Hum Brain Mapp"},{"issue":"11","key":"2143_CR13","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/STROKEAHA.109.572313","volume":"41","author":"A Ducros","year":"2010","unstructured":"Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke. 2010;41(11):2505\u201311. https:\/\/doi.org\/10.1161\/STROKEAHA.109.572313.","journal-title":"Stroke."},{"issue":"8","key":"2143_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.010","volume":"21","author":"Y Li","year":"2012","unstructured":"Li Y, Gor D, Walicki D, Jenny D, Jones D, Barbour P, Castaldo J. Spectrum and potential pathogenesis of reversible posterior leukoencephalopathy syndrome. J Stroke Cerebrovasc Dis. 2012;21(8):873\u201382. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2011.05.010.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"2143_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1600-0404.1972.tb07547.x","volume":"48","author":"E H\u00e4ggendal","year":"1972","unstructured":"H\u00e4ggendal E, Johansson B. On the pathophysiology of the increased cerebrovascular permeability in acute arterial hypertension in cats. Acta Neurol Scand. 1972;48(3):265\u201370. https:\/\/doi.org\/10.1111\/j.1600-0404.1972.tb07547.x.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"2143_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1528-1157.1998.tb01376.x","volume":"39","author":"R Bakshi","year":"1998","unstructured":"Bakshi R, Bates VE, Mechtler LL, Kinkel PR, Kinkel WR. Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia. 1998;39(3):295\u20139. https:\/\/doi.org\/10.1111\/j.1528-1157.1998.tb01376.x.","journal-title":"Epilepsia."},{"issue":"1","key":"2143_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2169\/internalmedicine.38.54","volume":"38","author":"Y Tajima","year":"1999","unstructured":"Tajima Y, Isonishi K, Kashiwaba T, Tashiro K. Two similar cases of encephalopathy, possibly a reversible posterior leukoencephalopathy syndrome: serial findings of magnetic resonance imaging, SPECT and angiography. Intern Med. 1999;38(1):54\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.38.54.","journal-title":"Intern Med"},{"issue":"2","key":"2143_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1051228404273820","volume":"15","author":"CE Doss-Esper","year":"2005","unstructured":"Doss-Esper CE, Singhal AB, Smith MS, Henderson GV. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in Guillain-Barre syndrome. J Neuroimaging. 2005;15(2):188\u201392. https:\/\/doi.org\/10.1177\/1051228404273820.","journal-title":"J Neuroimaging"},{"issue":"10","key":"2143_CR19","doi-asserted-by":"publisher","first-page":"e1746","DOI":"10.7759\/cureus.1746","volume":"9","author":"R Godasi","year":"2017","unstructured":"Godasi R, Rupareliya C, Bollu PC. Bilateral occipital lobe hemorrhages presenting as denial of blindness in posterior reversible encephalopathy syndrome- a rare combination of Anton syndrome and encephalopathy. Cureus. 2017;9(10):e1746. https:\/\/doi.org\/10.7759\/cureus.1746.","journal-title":"Cureus."},{"issue":"6","key":"2143_CR20","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/RHU.0b013e3182a21ffd","volume":"19","author":"N Gatla","year":"2013","unstructured":"Gatla N, Annapureddy N, Sequeira W, Jolly M. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol. 2013;19(6):334\u201340. https:\/\/doi.org\/10.1097\/RHU.0b013e3182a21ffd.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"2143_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5301\/jn.5000087","volume":"25","author":"MA Rizzo","year":"2012","unstructured":"Rizzo MA, Frediani F, Granata A, Ravasi B, Cusi D, Gallieni M. Neurological complications of hemodialysis: state of the art. J Nephrol. 2012;25(2):170\u201382. https:\/\/doi.org\/10.5301\/jn.5000087.","journal-title":"J Nephrol"},{"issue":"903","key":"2143_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/pmj.77.903.24","volume":"77","author":"RK Garg","year":"2001","unstructured":"Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J. 2001;77(903):24\u20138. https:\/\/doi.org\/10.1136\/pmj.77.903.24.","journal-title":"Postgrad Med J"},{"issue":"3\u20134","key":"2143_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000353731","volume":"123","author":"E Ermeidi","year":"2013","unstructured":"Ermeidi E, Balafa O, Spanos G, Zikou A, Argyropoulou M, Siamopoulos KC. Posterior reversible encephalopathy syndrome: a noteworthy syndrome in end-stage renal disease patients. Nephron Clin Pract. 2013;123(3\u20134):180\u20134. https:\/\/doi.org\/10.1159\/000353731.","journal-title":"Nephron Clin Pract"},{"issue":"6","key":"2143_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3747\/pdi.2011.00055","volume":"32","author":"A Ogawa","year":"2012","unstructured":"Ogawa A, Sugiyama H, Nakayama K, Morinaga H, Akagi S, Makino H. Reversible posterior leukoencephalopathy syndrome in a young adult patient receiving peritoneal dialysis. Perit Dial Int. 2012;32(6):587\u20139. https:\/\/doi.org\/10.3747\/pdi.2011.00055.","journal-title":"Perit Dial Int"},{"issue":"2","key":"2143_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/s-0031-1277984","volume":"31","author":"JL Seifter","year":"2011","unstructured":"Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol. 2011;31(2):139\u201343. https:\/\/doi.org\/10.1055\/s-0031-1277984.","journal-title":"Semin Neurol"},{"issue":"1","key":"2143_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-016-2078-0","volume":"128","author":"C Kamiya-Matsuoka","year":"2016","unstructured":"Kamiya-Matsuoka C, Paker AM, Chi L, Youssef A, Tummala S, Loghin ME. Posterior reversible encephalopathy syndrome in cancer patients: a single-institution retrospective study. J Neuro-Oncol. 2016;128(1):75\u201384. https:\/\/doi.org\/10.1007\/s11060-016-2078-0.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"2143_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2214\/ajr.159.2.1632361","volume":"159","author":"RB Schwartz","year":"1992","unstructured":"Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B, Holman BL. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol. 1992;159(2):379\u201383. https:\/\/doi.org\/10.2214\/ajr.159.2.1632361.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2143_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s13760-016-0703-5","volume":"117","author":"A Hinduja","year":"2017","unstructured":"Hinduja A, Habetz K, Raina SK, Fitzgerald RT. Predictors of intensive care unit utilization in patients with posterior reversible encephalopathy syndrome. Acta Neurol Belg. 2017;117(1):201\u20136. https:\/\/doi.org\/10.1007\/s13760-016-0703-5.","journal-title":"Acta Neurol Belg"},{"issue":"5","key":"2143_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10072-018-3651-4","volume":"40","author":"S Racchiusa","year":"2019","unstructured":"Racchiusa S, Mormina E, Ax A, Musumeci O, Longo M, Granata F. Posterior reversible encephalopathy syndrome (PRES) and infection: a systematic review of the literature. Neurol Sci. 2019;40(5):915\u201322. https:\/\/doi.org\/10.1007\/s10072-018-3651-4.","journal-title":"Neurol Sci"},{"issue":"1","key":"2143_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/jnnp-2017-316225","volume":"89","author":"B Gao","year":"2018","unstructured":"Gao B, Lyu C, Lerner A, McKinney AM. Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? J Neurol Neurosurg Psychiatry. 2018;89(1):14\u201320. https:\/\/doi.org\/10.1136\/jnnp-2017-316225.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"2143_CR31","first-page":"2179","volume":"27","author":"WS Bartynski","year":"2006","unstructured":"Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol. 2006;27(10):2179\u201390.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"2143_CR32","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.autrev.2015.05.006","volume":"14","author":"G Granata","year":"2015","unstructured":"Granata G, Greco A, Iannella G, Granata M, Manno A, Savastano E, Magliulo G. Posterior reversible encephalopathy syndrome--insight into pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 2015;14(9):830\u20136. https:\/\/doi.org\/10.1016\/j.autrev.2015.05.006.","journal-title":"Autoimmun Rev"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-021-02143-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02143-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T10:05:55Z","timestamp":1615284355000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02143-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2143"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02143-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no relevant conflicts of interests regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}